A joint effort by the Bill & Melinda Gates Foundation, the National Institutes of Health and Johnson & Johnson aims to develop a "global vaccine" to protect against HIV. The consortium is running a new, large-scale study called Imbokodo to test the efficacy of J&J's mosaic HIV-1 preventive vaccine candidate.
Public-private effort advances testing of HIV vaccine
Sign up for Specialty Pharmacy SmartBrief
News affecting the specialty pharmacy industry
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.